Botox price 2026 at Kind Global Clinic Myeongdong is structured as published per-area pricing across five brand tiers rather than a single flat rate. Korean-generic toxin (Hyatox by Huons, Liztox by Huons, Wondertox by Chong Kun Dang, Meditoxin by Medytox) starts at ₩39,000 ($28 USD) for crow's feet treatment. Coretox by Medytox (₩54,900-129,000 / $39-92 USD), Nabota by Daewoong (FDA-cleared as Jeuveau), Xeomin by Merz (₩65,000-199,000 / $46-142 USD), and Allergan Botox (₩82,000-299,000 / $59-214 USD) scale up per brand tier.
The 2026 price sheet covers six common indications: forehead horizontal lines (₩49,000-69,000), glabella vertical lines (₩49,000-69,000), crow's feet (₩39,000-59,000), masseter jaw reduction (₩199,000-299,000), calf trapezius slimming (₩299,000-499,000), and skin-Botox dermal-injection protocol. Per-area pricing reflects unit count required (forehead 8-12U, glabella 12-20U, crow's feet 6-12U, masseter 25-50U per side, calf 50-100U per side).
At Kind Global Clinic Myeongdong, both co-directors personally inject every Botox patient — there is no nurse delegation. Brand label, serial number, lot number, total unit count, and indication map are recorded on each patient's chart at the time of injection. Same KRW 2026 price applies to international and Korean patients with zero surcharge or hidden fees. Korean Botox pricing in 2026 is 50 to 70 percent less than United States equivalents (USD 250 to 600 per area in US) and 40 to 55 percent less than Japan.